Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study.

The Lancet. Microbe - 1 May 2024

Fountain-Jones Nicholas M, Vanhaeften Robert, Williamson Jan, Maskell Janelle, Chua I-Ly J, Charleston Michael, Cooley Louise

Abstract excerpt

INTRODUCTION: Continued SARS-CoV-2 infection among immunocompromised individuals is likely to play a role in generating genomic diversity and the emergence of novel variants. Antiviral treatments such as molnupiravir are used to mitigate severe COVID-19 outcomes, but the extended effects of these drugs on viral evolution in patients with chronic infections remain uncertain. This study investigates how...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Cytidine

Share to Genome, Viral

Share to Hydroxylamines

Share to Immunocompromised Host

Share to SARS-CoV-2

Source

Identifiers

PMID: 38527471
DOI: 10.1016/S2666-5247(23)00393-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study.PMID 38527471Read ↗

Antiviral treatments lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patientsSemantic proximity Read ↗

Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients.Semantic proximity Read ↗

SARS-CoV-2 evolution during prolonged infection in immunocompromised patientsSemantic proximity Read ↗

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysisSemantic proximity Read ↗

Combined Effects of Severe Immunocompromise and Prolonged Virus Shedding on Within-Host SARS-CoV-2 Evolution in COVID-19Semantic proximity Read ↗

SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection.Semantic proximity Read ↗

Impact of prolonged infection on SARS-CoV-2 evolution.Semantic proximity Read ↗

SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing.Semantic proximity Read ↗

Virus Evolution in Prolonged Infections of Immunocompromised Individuals.Semantic proximity Read ↗

SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.Semantic proximity Read ↗

Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.Semantic proximity Read ↗

Evolution of SARS-CoV-2 Viral Mutations in Individuals with Prolonged Infections.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.